The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Open accessAbstract
BACKGROUND: Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation is associated with an increased risk of stroke by a factor of 2.5; however, treatment with oral anticoagulation is of uncertain benefit. METHODS: We conducted a trial involving patients with subclinical atrial fibrillation lasting 6 minutes to 24 hours. Patients were randomly assigned in a double-blind, double-dummy design to receive apixaban at a dose of 5 mg twice daily (2.5 mg twice daily when indicated) or aspirin at a dose of 81 mg daily. The trial medication was discontinued and anticoagulation started if subclinical atrial fibrillation lasting more than 24 hours or clinical atrial fibrillation developed. The primary efficacy outcome, stroke or systemic embolism, was assessed in the intention-to-treat population (all the patients who had undergone randomization); the primary safety outcome, major bleeding, was assessed in the on-treatment population (all the patients who had undergone randomization and received at least one dose of the assigned trial drug, with follow-up censored 5 days after permanent discontinuation of trial medication for any reason). RESULTS: -VASc score of 3.9±1.1 (scores range from 0 to 9, with higher scores indicating a higher risk of stroke); 36.1% of the patients were women. After a mean follow-up of 3.5±1.8 years, stroke or systemic embolism occurred in 55 patients in the apixaban group (0.78% per patient-year) and in 86 patients in the aspirin group (1.24% per patient-year) (hazard ratio, 0.63; 95% confidence interval [CI], 0.45 to 0.88; P = 0.007). In the on-treatment population, the rate of major bleeding was 1.71% per patient-year in the apixaban group and 0.94% per patient-year in the aspirin group (hazard ratio, 1.80; 95% CI, 1.26 to 2.57; P = 0.001). Fatal bleeding occurred in 5 patients in the apixaban group and 8 patients in the aspirin group. CONCLUSIONS: Among patients with subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding. (Funded by the Canadian Institutes of Health Research and others; ARTESIA ClinicalTrials.gov number, NCT01938248.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., Albert, C. M., Anderson, C. S., Antoniou, S., Benjamin, E. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026693 · Cited by 537
Self-citationAnticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
Kirchhof, P., Toennis, T., Goette, A., Camm, A. J., Diener, H. C., Becher, N., Bertaglia, E., Blomstrom Lundqvist, C., Borlich, M., Brandes, A., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2303062 · Cited by 418
Self-citationLopes, R. D., Alings, M., Connolly, S. J., Beresh, H., Granger, C. B., Mazuecos, J. B., Boriani, G., Nielsen, J. C., Conen, D., Hohnloser, S. H., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.04.008 · Cited by 290
Self-citationReiffel, J. A., Verma, A., Kowey, P. R., Halperin, J. L., Gersh, B. J., Wachter, R., Pouliot, E., Ziegler, P. D., & for the REVEAL AF Investigators (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3180 · Cited by 265
Subclinical Atrial Fibrillation in Older Patients
Healey, J. S., Alings, M., Ha, A., Leong-Sit, P., Birnie, D. H., de Graaf, J. J., Freericks, M., Verma, A., Wang, J., Leong, D., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028845 · Cited by 249
Self-citationGorenek, B., Bax, J., Boriani, G., Chen, S.-A., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L.-Å., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 247
Self-citationAndrade, J. G., Verma, A., Mitchell, L. B., Parkash, R., Leblanc, K., Atzema, C., Healey, J. S., Bell, A., Cairns, J., Connolly, S., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.026 · Cited by 233
Self-citationNatural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders
Diederichsen, S. Z., Haugan, K., Brandes, A., Lanng, M. B., Graff, C., Krieger, D. W., Kronborg, C., Holst, A. G., Køber, L., Højberg, S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.050 · Cited by 138
Ng, K. H., Shestakovska, O., Connolly, S. J., Eikelboom, J. W., Avezum, Á., Díaz, R., Lanas, F. T., Yusuf, S., & Hart, R. G. (2015) · Age and Ageing · doi:10.1093/ageing/afv156 · Cited by 113
Self-citationAtrial high-rate episodes and stroke prevention
Camm, A. J., SIMANTIRAKIS, E. N., Goette, A., Lip, G. Y. H., Vardas, P. E., Calvert, M., CHLOUVERAKIS, G. I., Diener, H., & Kirchhof, P. F. (2016) · EP Europace · doi:10.1093/europace/euw279 · Cited by 112
Self-citationBrandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., Chow, C. K., Ding, E., Engdahl, J., Gibson, C. M., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058911 · Cited by 96
Self-citationDiederichsen, S. Z., Haugan, K., Brandes, A., Graff, C., Krieger, D. W., Kronborg, C., Holst, A. G., Nielsen, J. B., Køber, L., Højberg, S., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.09.009 · Cited by 49
Asymptomatic Atrial Fibrillation: The Case for Screening to Prevent Stroke
Freedman, B., & Lowres, N. (2015) · JAMA · doi:10.1001/jama.2015.9846 · Cited by 47
Eerenberg, E. S., Cohen, A. T., Middeldorp, S., Raskob, G. E., Buller, H. R., Bleker, S. M., & Brekelmans, M. P. A. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-12-0946 · Cited by 47
Perry, J. J., Sivilotti, M. L. A., Émond, M., Stiell, I. G., Stotts, G., Lee, J. S., Worster, A., Morris, J., Cheung, K. W., Jin, A. Y., et al. (2021) · BMJ · doi:10.1136/bmj.n49 · Cited by 37
Hess, P. L., Healey, J. S., Granger, C. B., Connolly, S. J., Ziegler, P., Alexander, J. H., Kowey, P. R., Ruff, C. T., Flaker, G., Halperin, J. L., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5167 · Cited by 31
Self-citationMcIntyre, W. F., Yong, J. H. E., Sandhu, R. K., Gladstone, D. J., Simek, K. D., Liu, Y. Y., Quinn, F. R., Tytus, R. H., Zizzo, D., Henein, S., et al. (2019) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2019.11.040 · Cited by 13
Self-citation
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Artificial intelligence in cardiovascular medicine: clinical applications
Lüscher, T. F., Wenzl, F. A., D’Ascenzo, F., Friedman, P. A., & Antoniades, C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae465 · Cited by 160
“21 Arrhythmia classification has been well studied.”
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
Rienstra, M., Tzeis, S., Bunting, K. V., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Sanders, P., Svennberg, E., Casado-Arroyo, R., Dwight, J., et al. (2024) · Europace · doi:10.1093/europace/euae298 · Cited by 128
Metadata
- Authors
- Healey, J. S., Lopes, R. D., Granger, C. B., Alings, M., Rivard, L., McIntyre, W. F., Atar, D., Birnie, D. H., Boriani, G., Camm, A. J., Conen, D., Erath, J. W., Gold, M. R., Hohnloser, S. H., Ip, J., Kautzner, J., Kutyifa, V., Linde, C., Mabo, P., Mairesse, G., Benezet Mazuecos, J., Cosedis Nielsen, J., Philippon, F., Proietti, M., Sticherling, C., Wong, J. A., Wright, D. J., Zarraga, I. G., Coutts, S. B., Kaplan, A., Pombo, M., Ayala-Paredes, F., Xu, L., Simek, K., Nevills, S., Mian, R., & Connolly, S. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2024-01-11
- Volume
- 390
- Issue
- 2
- Pages
- 107-117
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4388609933
- Cited by
- 451
- References
- 27
- FWCI
- 79.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.